Pancreatic cancer: Current status and Challenges
- PMID: 29404265
- PMCID: PMC5795623
- DOI: 10.1007/s40495-017-0112-3
Pancreatic cancer: Current status and Challenges
Abstract
Purpose of the review: The 5-year survival rate of patients with pancreatic cancer (PanCA) has remained stagnant. Unfortunately, the incidence is almost equal to mortality rates. These facts underscore the importance of concerted efforts to understand the pathology of this disease. Deregulation of multiple signaling pathways involved in a wide variety of cellular processes including proliferation, apoptosis, invasion, and metastasis contribute not only to cancer development but also to therapeutic resistance. The purpose of this review is to summarize current understanding of etiological factors including emerging evidence on the role of infectious agents, factors associated with therapeutic resistance and therapeutic options.
Recent findings: The unique aspect of PanCA is "desmoplasia", a process that involves proliferation of stromal fibroblasts and collagen deposition in and around the filtrating cancer. Recent studies have identified pancreatic stellate cells (PSCs) as a potential source of such desmoplasia. Biphasic interactions between PSCs and cancer cells, endothelial cells, and/or myeloid derived suppressor cells in the tumor microenvironment contribute to pancreatic carcinogenesis.
Summary: We summarize limitations of current therapeutic approaches and potential strategies to overcome these limitations using natural products including botanicals as adjuvant/neo-adjuvant for effective management of PanCA.
Keywords: Chemotherapy; Gemcitabine; Natural products; Pancreatic cancer.
Conflict of interest statement
Conflict of interest statement: Authors declare no conflicts of interest.
Similar articles
-
Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.Cancer Res. 2013 Apr 1;73(7):2345-56. doi: 10.1158/0008-5472.CAN-12-3180. Epub 2013 Jan 24. Cancer Res. 2013. PMID: 23348422
-
Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.BMC Cancer. 2020 Jul 13;20(1):651. doi: 10.1186/s12885-020-07135-2. BMC Cancer. 2020. PMID: 32660466 Free PMC article.
-
Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.Eur J Cancer. 2014 Oct;50(15):2570-82. doi: 10.1016/j.ejca.2014.06.021. Epub 2014 Aug 1. Eur J Cancer. 2014. PMID: 25091797 Review.
-
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.Eur J Pharmacol. 2024 Mar 15;967:176357. doi: 10.1016/j.ejphar.2024.176357. Epub 2024 Feb 1. Eur J Pharmacol. 2024. PMID: 38309677 Review.
-
Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction.Front Physiol. 2013 Nov 1;4:318. doi: 10.3389/fphys.2013.00318. Front Physiol. 2013. PMID: 24198790 Free PMC article. Review.
Cited by
-
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.Cell Prolif. 2019 May;52(3):e12603. doi: 10.1111/cpr.12603. Epub 2019 Apr 1. Cell Prolif. 2019. PMID: 30932257 Free PMC article.
-
Chemogenomic study of gemcitabine using Saccharomyces cerevisiae as model cell-molecular insights about chemoresistance.Braz J Microbiol. 2020 Jun;51(2):489-496. doi: 10.1007/s42770-019-00154-7. Epub 2019 Sep 12. Braz J Microbiol. 2020. PMID: 31515725 Free PMC article.
-
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling.Cancer Cell Int. 2021 Aug 19;21(1):436. doi: 10.1186/s12935-021-02143-z. Cancer Cell Int. 2021. PMID: 34412631 Free PMC article.
-
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance.Pancreas. 2019 Apr;48(4):555-567. doi: 10.1097/MPA.0000000000001277. Pancreas. 2019. PMID: 30946238 Free PMC article.
-
Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis via suppression of sirtuin 3 in pancreatic cancer.World J Gastroenterol. 2018 Nov 21;24(43):4893-4905. doi: 10.3748/wjg.v24.i43.4893. World J Gastroenterol. 2018. PMID: 30487699 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials